A database of FDA approved therapeutic peptides and proteins
ID1129 | ThPPIDTh1018 | NameSecretin | Peptide SequenceHSDGTFTSELSRLRDSARLQ Full view | Length27 | Functional ClassificationIV | DiseaseHormonal disorders | BrandSecreFlo | CompanyRepligen Corp | Physical AppearanceLyophilized white powder | Route of AdministartionIntravenous infusion | CategoryDiagnostic Agents | TargetSecretin receptor |
ID1130 | ThPPIDTh1018 | NameSecretin | Peptide SequenceHSDGTFTSELSRLRDSARLQ Full view | Length27 | Functional ClassificationIV | DiseaseHormonal disorders | BrandSecremax | CompanyRepligen Corp | Physical AppearanceSolution | Route of AdministartionIntravenous | CategoryDiagnostic Agents | TargetSecretin receptor |
ID1205 | ThPPIDTh1027 | NameInsulin Regular | Peptide SequenceA-chain:GIVEQCCTSIC< Full view | Length51 | Functional ClassificationIa | DiseaseGenetic/Hormonal | BrandHumulin R | CompanyEli Lilly and Company | Physical AppearanceSterile, clear, aqueous, and colorless solution | Route of AdministartionSubcutaneous injection in the abdominal wall, the thigh, the gluteal region or in the upper arm and Intravenousadministration of Humulin R (insulin (human recombinant)) U-100 is possible under medical supervision. | CategoryAntidiabetic Agents | TargetInsulin receptor,Insulin-like growth factor 1 receptor,Retinoblastoma-associated protein,Cathepsin D,Insulin-degrading enzyme,Neuroendocrine convertase 2,Carboxypeptidase E,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-r |
ID1206 | ThPPIDTh1027 | NameInsulin Regular | Peptide SequenceA-chain:GIVEQCCTSIC< Full view | Length51 | Functional ClassificationIa | DiseaseGenetic/Hormonal | BrandNovolin R | CompanyNovo Nordisk | Physical AppearanceSterile, clear, aqueous, and colorless solution | Route of AdministartionSubcutaneous and Intravenous infusion | CategoryAntidiabetic Agents | TargetInsulin receptor,Insulin-like growth factor 1 receptor,Retinoblastoma-associated protein,Cathepsin D,Insulin-degrading enzyme,Neuroendocrine convertase 2,Carboxypeptidase E,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-r |
ID1215 | ThPPIDTh1029 | NameMenotropins | Peptide SequenceAlpha-Chain(LH):APD< Full view | Length222 | Functional ClassificationIb | DiseaseHormonal disorders | BrandMenopur | CompanyN.A. | Physical AppearanceSterile, lyophilized powder which is reconstitution with sterile 0.9% Sodium Chloride Injection. | Route of AdministartionSubcutaneous Injection | CategoryFertility Agents | TargetFollicle-stimulating hormone receptor,Lutropin-choriogonadotropic hormone receptor |
ID1216 | ThPPIDTh1029 | NameMenotropins | Peptide SequenceAlpha-Chain(LH):APD< Full view | Length222 | Functional ClassificationIb | DiseaseHormonal disorders | BrandRepronex | CompanyN.A. | Physical AppearanceSterile, lyophilized form | Route of AdministartionSubcutaneous or Intramuscular Injection. | CategoryFertility Agents | TargetFollicle-stimulating hormone receptor,Lutropin-choriogonadotropic hormone receptor |
ID1252 | ThPPIDTh1035 | NameGlucagon recombinant | Peptide SequenceHSQGTFTSDYSKYLDSRRAQ Full view | Length29 | Functional ClassificationIV | DiseaseHormonal/Metabolic/genetic | BrandGlucaGen | CompanyNovo Nordisk | Physical AppearanceSterile, lyophilized white powder | Route of AdministartionSubcutaneous, Intramuscular, or Intravenous infusion | CategoryHypoglycemic Agents | TargetGlucagon receptor,Glucagon-like peptide 2 receptor,Glucagon-like peptide 1 receptor |
ID1253 | ThPPIDTh1035 | NameGlucagon recombinant | Peptide SequenceHSQGTFTSDYSKYLDSRRAQ Full view | Length29 | Functional ClassificationIV | DiseaseHormonal/Metabolic/genetic | BrandGlucagon | CompanyEli Lilly | Physical AppearancePowder | Route of AdministartionSubcutaneously or Intramuscularly Injection | CategoryHypoglycemic Agents | TargetGlucagon receptor,Glucagon-like peptide 2 receptor,Glucagon-like peptide 1 receptor |
ID1269 | ThPPIDTh1039 | NameLutropin alfa | Peptide SequenceAlpha Chain: APDVQDC Full view | Length213 | Functional ClassificationIb | DiseaseHormonal | BrandLuveris | CompanySerono | Physical AppearanceWhite lyophilised pellet withg clear colourless solvent to make solution | Route of AdministartionSubcutaneous (SC) administration | CategoryFertility Agents | TargetLutropin-choriogonadotropic hormone receptor |
ID1275 | ThPPIDTh1040 | NameInsulin Lispro | Peptide SequenceA chain:GIVEQCCTSICS Full view | Length51 | Functional ClassificationIa | DiseaseHormonal/Metabolic/genetic | BrandHumalog | CompanyEli Lilly | Physical AppearanceSterile, aqueous, clear, and colorless solution | Route of AdministartionSubcutaneous and Intravenous infusion | CategoryHypoglycemic Agents, Antidiabetic agents | TargetInsulin receptor,Insulin-like growth factor 1 receptor |
ID1276 | ThPPIDTh1040 | NameInsulin Lispro | Peptide SequenceA chain:GIVEQCCTSICS Full view | Length51 | Functional ClassificationIa | DiseaseHormonal/Metabolic/genetic | BrandHumalog KwikPen | CompanyEli Lilly | Physical AppearanceSolution | Route of AdministartionSubcutaneous injection | CategoryHypoglycemic Agents, Antidiabetic agents | TargetInsulin receptor,Insulin-like growth factor 1 receptor |
ID1277 | ThPPIDTh1040 | NameInsulin Lispro | Peptide SequenceA chain:GIVEQCCTSICS Full view | Length51 | Functional ClassificationIa | DiseaseHormonal/Metabolic/genetic | BrandHumalog Pen | CompanyEli Lilly | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryHypoglycemic Agents, Antidiabetic agents | TargetInsulin receptor,Insulin-like growth factor 1 receptor |
ID1283 | ThPPIDTh1041 | NameInsulin Glargine | Peptide SequenceA-chain:GIVEQCCTSICS Full view | Length53 | Functional ClassificationIa | DiseaseHormonal/Metabolic/genetic | BrandLantus | CompanySanofi-Aventis | Physical AppearanceSolution | Route of AdministartionSubcutaneous injection | CategoryHypoglycemic Agents, Antidiabetic agents | TargetInsulin receptor,Insulin-like growth factor 1 receptor |
ID1284 | ThPPIDTh1041 | NameInsulin Glargine | Peptide SequenceA-chain:GIVEQCCTSICS Full view | Length53 | Functional ClassificationIa | DiseaseHormonal/Metabolic/genetic | BrandLantus OptiSet | CompanyN.A. | Physical AppearanceSolution | Route of AdministartionSubcutaneous injection | CategoryHypoglycemic Agents, Antidiabetic agents | TargetInsulin receptor,Insulin-like growth factor 1 receptor |
ID1285 | ThPPIDTh1041 | NameInsulin Glargine | Peptide SequenceA-chain:GIVEQCCTSICS Full view | Length53 | Functional ClassificationIa | DiseaseHormonal/Metabolic/genetic | BrandLantus SoloStar | CompanyN.A. | Physical AppearanceSolution | Route of AdministartionSubcutaneous injection | CategoryHypoglycemic Agents, Antidiabetic agents | TargetInsulin receptor,Insulin-like growth factor 1 receptor |
ID1372 | ThPPIDTh1055 | NameFollitropin beta | Peptide SequenceA Chain: APDVQDCPECT Full view | Length204 | Functional ClassificationIb | DiseaseHormonal disorders | BrandFollistim AQ | CompanyMerck | Physical AppearanceSterile aqueous solution | Route of AdministartionSubcutaneous or Intramuscular administration | CategoryFertility Agents | TargetFollicle-stimulating hormone receptor |
ID1375 | ThPPIDTh1056 | NameVasopressin | Peptide SequenceCYFQNCPRG Full view | Length9 | Functional ClassificationIb | DiseaseHormonal | BrandPitressin | CompanyJHP Pharmaceuticals | Physical AppearanceSterile, aqueous solution of synthetic vasopressin | Route of AdministartionIntramuscular or Subcutaneous use | CategoryAntidiuretic Agents | TargetVasopressin V2 receptor,Vasopressin V1a receptor,Vasopressin V1b receptor |
ID1382 | ThPPIDTh1060 | NameInsulin, porcine | Peptide SequenceA chain: GIVEQCCTSIC Full view | Length51 | Functional ClassificationIa | DiseaseHormonal/Metabolic | Brandvetsulin | CompanyIntervet Inc (Merck Animal Health) | Physical AppearanceSterile injectable suspension in multidose vials containing 10 mL of 40 IU/mL porcine insulin zinc suspension | Route of AdministartionSubcutaneous Injection | CategoryHypoglycemic Agents | TargetInterferon alpha/beta receptor 2,Interferon alpha/beta receptor 1, Hyaluronan, Transforming growth factor beta-1 |
ID1415 | ThPPIDTh1069 | NamePegvisomant | Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view | Length191 | Functional ClassificationIIa | DiseaseHormonal | BrandSOMAVERT | CompanyPfizer | Physical AppearanceSterile, white lyophilized powder | Route of AdministartionSubcutaneous Injection | CategoryHormone Replacement Agents | TargetB-lymphocyte antigen CD20,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c |
ID1439 | ThPPIDTh1077 | NameUrofollitropin | Peptide SequenceAlpha chain:APDVQDCP Full view | Length203 | Functional ClassificationIb | DiseaseHormonal | BrandBRAVELLE | CompanyFerring Pharmaceuticals Inc. | Physical AppearanceSterile, lyophilized powder used after reconstitution with sterile 0.9% Sodium Chloride Injection | Route of AdministartionIntramuscular and Subcutaneous administration | CategoryFertility Agents | TargetGlutamate carboxypeptidase 2 |
ID1440 | ThPPIDTh1077 | NameUrofollitropin | Peptide SequenceAlpha chain:APDVQDCP Full view | Length203 | Functional ClassificationIb | DiseaseHormonal | BrandMetrodin | CompanyN.A. | Physical AppearanceSterile, lypholized form contains an acidic, water soluble glycoprotein biologically standardized for FSH gonadotropin activity | Route of AdministartionIntramuscular injection. | CategoryFertility Agents | TargetGlutamate carboxypeptidase 2 |
ID1441 | ThPPIDTh1077 | NameUrofollitropin | Peptide SequenceAlpha chain:APDVQDCP Full view | Length203 | Functional ClassificationIb | DiseaseHormonal | BrandFertinex | CompanyN.A. | Physical AppearanceSterile, lyophilized form contains an acidic, water soluble glycoprotein biologically standardized for FSH gonadotropin activity | Route of AdministartionSubcutaneous injection. | CategoryFertility Agents | TargetGlutamate carboxypeptidase 2 |
ID1447 | ThPPIDTh1080 | NameChoriogonadotropin Alfa | Peptide SequenceAlpha chain: APDVQDC Full view | Length237 | Functional ClassificationIb | DiseaseHormonal | BrandChoriogonadotropin alfa | CompanyEmd serono inc, Ferring pharmaceuticals inc, App pharmaceuticals llc, Bel mar laboratories inc, Bris | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryFertility Agents and Gonadotropins | TargetIntegrin alpha-L, Low affinity immunoglobulin gamma Fc region receptor III-B, Complement C1r subcomponent, Complement C1q subcomponent subunit A, Complement C1q subcomponent subunit B, Complement C1q subcomponent subunit C, Low affinity immunoglobulin gamma Fc region receptor III-A, High affinity immunoglobulin gamma Fc receptor I, Low affinity immunoglobulin gamma Fc region receptor II-a, Low affinity immunoglobulin gamma Fc region receptor II-b, Low affinity immunoglobulin gamma Fc region receptor II-c |
ID1460 | ThPPIDTh1087 | NameOxytocin | Peptide SequenceCYIQNCPLG Full view | Length9 | Functional ClassificationIb | DiseaseHormonal | BrandPitocin | CompanyJHP Pharmaceuticals | Physical AppearanceSterile, clear, colorless aqueous solution of synthetic oxytocin | Route of AdministartionIntravenous infusion | CategoryOxytocics, Anti-tocolytic Agents and Labor Induction Agents | TargetInterferon alpha/beta receptor 2,Interferon alpha/beta receptor 1, Globotriaosylceramide |
ID1478 | ThPPIDTh1098 | NameExenatide | Peptide SequenceHGEGTFTSDLSKQMEEEAVR Full view | Length39 | Functional ClassificationIb | DiseaseHormonal/Metabolic | BrandBYETTA | CompanyN.A. | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryHypoglycemic Agents | TargetGlucagon-like peptide 1 receptor |
ID1479 | ThPPIDTh1098 | NameExenatide | Peptide SequenceHGEGTFTSDLSKQMEEEAVR Full view | Length39 | Functional ClassificationIb | DiseaseHormonal/Metabolic | BrandBYDUREON | CompanyAmylin Pharmaceuticals | Physical AppearanceWhite to off-white powder that is available in a dosage strength of 2 mg exenatide per vial or per pen | Route of AdministartionN.A. | CategoryHypoglycemic Agents | TargetGlucagon-like peptide 1 receptor |
ID1480 | ThPPIDTh1099 | NameMecasermin | Peptide SequenceGPETLCGAELVDALQFVCGD Full view | Length70 | Functional ClassificationIb | DiseaseHormonal | BrandN.A. | CompanyN.A. | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryN.A. | TargetInsulin-like growth factor 1 receptor,Insulin-like growth factor-binding protein 3,Insulin receptor,Cation-independent mannose-6-phosphate receptor |
ID1482 | ThPPIDTh1100 | NamePramlintide | Peptide SequenceKCNTATCATQRLANFLVHSS Full view | Length37 | Functional ClassificationIa | DiseaseHormonal/Metabolic | BrandSymlin | CompanyAmylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca) | Physical AppearanceClear, isotonic, sterile solution | Route of AdministartionSubcutaneous injection | CategoryN.A. | TargetCalcitonin receptor,Receptor activity-modifying protein 1,Receptor activity-modifying protein 2,Receptor activity-modifying protein 3 |
ID1500 | ThPPIDTh1103 | NameCosyntropin | Peptide SequenceACTH(1-24): SYSM Full view | Length24 | Functional ClassificationIV | DiseaseHormonal | BrandCortrosyn | CompanyAmphastar Pharmaceuticals | Physical AppearanceN.A. | Route of AdministartionIntravenous injection, Intravenous infusion, Intramuscular injection | CategoryHormones and Diagnostic Agents | TargetAdrenocorticotropic hormone receptor |
ID1501 | ThPPIDTh1104 | NameCorticotropin | Peptide SequenceSYSMEHFRWGKPVGKKRRPV Full view | Length39 | Functional ClassificationIV | DiseaseHormonal | BrandH.P. Acthar | CompanyQuestcor Pharmaceuticals, Inc. | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryN.A. | TargetN.A. |
ID1502 | ThPPIDTh1105 | NameInsulin Aspart | Peptide SequenceA chain: GIVEQCCTSIC Full view | Length51 | Functional ClassificationIa | DiseaseHormonal/Metabolic | BrandNovoLog | CompanyNovo Nordisk | Physical AppearanceSterile, aqueous, clear, and colorless solution | Route of AdministartionSubcutaneous injection, Intravenous injection | CategoryHypoglycemic Agents and Antidiabetic Agents | TargetInsulin receptor |
ID1503 | ThPPIDTh1105 | NameInsulin Aspart | Peptide SequenceA chain: GIVEQCCTSIC Full view | Length51 | Functional ClassificationIa | DiseaseHormonal/Metabolic | BrandNovoLog Mix 50/50 | CompanyNovo Nordisk | Physical AppearanceUniform, white, sterile suspension that contains insulin aspart | Route of AdministartionSubcutaneous injection | CategoryHypoglycemic Agents and Antidiabetic Agents | TargetInsulin receptor |
ID1504 | ThPPIDTh1105 | NameInsulin Aspart | Peptide SequenceA chain: GIVEQCCTSIC Full view | Length51 | Functional ClassificationIa | DiseaseHormonal/Metabolic | BrandNovoLog Mix 70/30 | CompanyNovo Nordisk | Physical AppearanceUniform, white, sterile suspension that contains insulin aspart 100 Units/mL. | Route of AdministartionSubcutaneous injection | CategoryHypoglycemic Agents and Antidiabetic Agents | TargetInsulin receptor |
ID1511 | ThPPIDTh1106 | NameInsulin Detemir | Peptide SequenceA chain: GIVEQCCTSIC Full view | Length51 | Functional ClassificationIa | DiseaseHormonal/Metabolic | BrandLEVEMIR | CompanyNovo Nordisk | Physical AppearanceClear, colorless, aqueous, neutral sterile solution | Route of AdministartionSubcutaneous injection | CategoryAntidiabetic Agents | TargetInsulin receptor |
ID1520 | ThPPIDTh1107 | NameInsulin Glulisine | Peptide SequenceA chain: GIVEQCCTSIC Full view | Length51 | Functional ClassificationIb | DiseaseHormonal/Metabolic | BrandAPIDRA | Companysanofi-aventis | Physical AppearanceSterile, aqueous, clear, and colorless solution | Route of AdministartionN.A. | CategoryAntidiabetic Agents | TargetInsulin receptor |
ID1549 | ThPPIDTh1118 | NameSulodexide | Peptide SequenceN.A. Full view | Length0 | Functional ClassificationIIIc | DiseaseHormonal/genetic/Hematological/N.A. | BrandSULODEXIDE | CompanySyntex S.A | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryAntithrombins and Fibrinolytic Agents and Hypoglycemic Agents and Anticoagulants and Hypolipidemic Agents | TargetHeparin cofactor 2,Antithrombin-III |
ID1576 | ThPPIDTh1124 | NameLiraglutide | Peptide SequenceHAEGTFTSDVSSYLEGQAAK Full view | Length33 | Functional ClassificationIb | DiseaseHormonal | BrandSaxenda | CompanyNovo Nordisk | Physical AppearanceClear, colorless solution | Route of AdministartionSubcutaneous injection | CategoryN.A. | TargetGlucagon-like peptide 1 receptor |
ID1577 | ThPPIDTh1124 | NameLiraglutide | Peptide SequenceHAEGTFTSDVSSYLEGQAAK Full view | Length33 | Functional ClassificationIb | DiseaseHormonal | BrandVictoza | CompanyNovo Nordisk | Physical AppearanceClear, colorless solution. | Route of AdministartionSubcutaneous injection | CategoryN.A. | TargetGlucagon-like peptide 1 receptor |
ID1600 | ThPPIDTh1127 | NameBuserelin | Peptide SequenceN.A. Full view | Length0 | Functional ClassificationIIIc | DiseaseCancer/Hormonal | BrandSuprecur (Nasal Spray Solution) | CompanySanofi-Aventis | Physical Appearance150 micrograms Nasal Spray Solution | Route of AdministartionNasal spray | CategoryN.A. | TargetLutropin-choriogonadotropic hormone receptor,Gonadotropin-releasing hormone receptor |
ID1601 | ThPPIDTh1127 | NameBuserelin | Peptide SequencepGlu-His-Trp-Ser-Tyr Full view | Length9 | Functional ClassificationIIIc | DiseaseCancer/Hormonal | BrandSuprecur (injection) | CompanySanofi-Aventis | Physical Appearance1mg/ml Injection | Route of AdministartionSubcutaneous injection | CategoryN.A. | TargetLutropin-choriogonadotropic hormone receptor,Gonadotropin-releasing hormone receptor |
ID1602 | ThPPIDTh1128 | NameVelaglucerase Alfa | Peptide SequenceARPCIPKSFGYSSVVCVCNA Full view | Length497 | Functional ClassificationIa | DiseaseHormonal | BrandVPRIV | CompanyShire | Physical AppearanceSterile, preservative free, lyophilized powder | Route of AdministartionIntravenous infusion | CategoryEnzymes | TargetGlucosylceramidase |
ID1603 | ThPPIDTh1129 | NameTesamorelin | Peptide SequenceYADAIFTNSYRKVLGQLSAR Full view | Length44 | Functional ClassificationIb | DiseaseHormonal | BrandEgrifta | CompanyTheratechnologies | Physical AppearanceSterile, white to off-white, preservative-free lyophilized powder | Route of AdministartionSubcutaneous injection | CategoryN.A. | TargetGrowth hormone-releasing hormone receptor |
ID1608 | ThPPIDTh1131 | NameTaliglucerase Alfa | Peptide SequenceEFARPCIPKSFGYSSVVCVC Full view | Length504 | Functional ClassificationIa | DiseaseHormonal | BrandElelyso | CompanyPfizer | Physical AppearanceSterile, non-pyrogenic, lyophilized product. | Route of AdministartionIntravenous infusion | CategoryEnzymes | TargetGlucocerebroside |
ID1621 | ThPPIDTh1134 | NameAsparaginase Erwinia Chrysanthemi | Peptide SequenceADKLPNIVILATGGTIAGSA Full view | Length327 | Functional ClassificationIc | DiseaseHormonal | BrandErwinaze | CompanyEUSA Pharma | Physical AppearanceSterile, lyophilized, white powder in vials. | Route of AdministartionIntramuscular injection | CategoryEnzymes | TargetN.A. |
ID1623 | ThPPIDTh1136 | NameGlucarpidase | Peptide SequenceALAQKRDNVLFQAATDEQPA Full view | Length393 | Functional ClassificationIc | DiseaseHormonal | BrandVoraxaze | CompanyBTG International | Physical AppearanceSterile, preservative-free, white lyophilized powder in single-use vials | Route of AdministartionIntravenous injection | CategoryEnzymes | TargetMethotrexate |
ID1634 | ThPPIDTh1140 | NameInsulin, Isophane Or Nph Insulin (Neutral Protamine Hagedorn) | Peptide SequenceA chain: GIVEQCCTSIC Full view | Length51 | Functional ClassificationIa | DiseaseHormonal/Metabolic | BrandNovolin N | CompanyNovo Nordisk | Physical AppearanceNovolin N InnoLet (nph, human insulin isophane suspension 3 ml disposable prefilled syringe) | Route of AdministartionSubcutaneous injection | CategoryHypoglycemic Agents and Antidiabetic Agents | TargetInsulin receptor |
ID1638 | ThPPIDTh1144 | NameFollitropin Alpha | Peptide SequenceN.A. Full view | Length0 | Functional ClassificationIb | DiseaseAdjunct therapy/ Hormonal | BrandGonal-F | CompanySerono Laboratories | Physical AppearanceSterile, lyophilized powder. | Route of AdministartionSubcutaneous injection | CategoryN.A. | TargetN.A. |
ID1639 | ThPPIDTh1144 | NameFollitropin Alpha | Peptide SequenceN.A. Full view | Length0 | Functional ClassificationIb | DiseaseAdjunct therapy/ Hormonal | BrandGonal-f RFF | CompanyEMD SERONO | Physical AppearanceSterile, lyophilized powde | Route of AdministartionSubcutaneous injection | CategoryN.A. | TargetN.A. |
ID1655 | ThPPIDTh1151 | NameSomatotropin Recombinant | Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view | Length192 | Functional ClassificationIb | DiseaseHormonal/Metabolic | BrandNutropinAQ | CompanyGenentech Inc. | Physical AppearanceSterile, white lyophilized powder intended for subcutaneous administration after reconstitution with Bacteriostatic Water | Route of AdministartionSubcutaneous administration | CategoryHormone Replacement Agents | TargetGrowth hormone receptor, Prolactin receptor |
ID1656 | ThPPIDTh1151 | NameSomatotropin Recombinant | Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view | Length192 | Functional ClassificationIb | DiseaseHormonal/Metabolic | BrandBioTropin | CompanyBio-Technology General (Israel) Ltd. | Physical AppearanceSterile, white, lyophilized powder | Route of AdministartionSubcutaneous administration | CategoryHormone Replacement Agents | TargetGrowth hormone receptor, Prolactin receptor |